169 related articles for article (PubMed ID: 11313272)
21. Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways.
Glasow A; Prodromou N; Xu K; von Lindern M; Zelent A
Blood; 2005 Jan; 105(1):341-9. PubMed ID: 15339853
[TBL] [Abstract][Full Text] [Related]
22. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia.
Adida C; Recher C; Raffoux E; Daniel MT; Taksin AL; Rousselot P; Sigaux F; Degos L; Altieri DC; Dombret H
Br J Haematol; 2000 Oct; 111(1):196-203. PubMed ID: 11091201
[TBL] [Abstract][Full Text] [Related]
23. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
24. Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway.
Zhang Y; Chen HX; Zhou SY; Wang SX; Zheng K; Xu DD; Liu YT; Wang XY; Wang X; Yan HZ; Zhang L; Liu QY; Chen WQ; Wang YF
Mol Cancer; 2015 Mar; 14():56. PubMed ID: 25890196
[TBL] [Abstract][Full Text] [Related]
25. Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling.
Morgan MA; Dolp O; Reuter CW
Blood; 2001 Mar; 97(6):1823-34. PubMed ID: 11238126
[TBL] [Abstract][Full Text] [Related]
26. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
Hassan HT; Zander A
Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
[TBL] [Abstract][Full Text] [Related]
27. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
[TBL] [Abstract][Full Text] [Related]
28. Blockade of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim.
Zhang W; Konopleva M; Burks JK; Dywer KC; Schober WD; Yang JY; McQueen TJ; Hung MC; Andreeff M
Cancer Res; 2010 Mar; 70(6):2424-34. PubMed ID: 20215498
[TBL] [Abstract][Full Text] [Related]
29. [Experimental study on activating antileukemic T cells by vaccination with dendritic cells pulsed with survivin].
Zhang XH; Xia LH; Liu ZP; Wei WN; Hu Y; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):66-9. PubMed ID: 12667293
[TBL] [Abstract][Full Text] [Related]
30. Survivin and aven: two distinct antiapoptotic signals in acute leukemias.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Sahin B; Burgut R
Ann Oncol; 2003 Jul; 14(7):1045-50. PubMed ID: 12853345
[TBL] [Abstract][Full Text] [Related]
31. Effects of FLT3 ligand on proliferation and survival of myeloid leukemia cells.
Drexler HG; Meyer C; Quentmeier H
Leuk Lymphoma; 1999 Mar; 33(1-2):83-91. PubMed ID: 10194124
[TBL] [Abstract][Full Text] [Related]
32. siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells.
Karami H; Baradaran B; Esfahani A; Estiar MA; Naghavi-Behzad M; Sakhinia M; Sakhinia E
Asian Pac J Cancer Prev; 2013; 14(12):7719-24. PubMed ID: 24460358
[TBL] [Abstract][Full Text] [Related]
33. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y
Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579
[TBL] [Abstract][Full Text] [Related]
34. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.
Schwaller J; Pabst T; Koeffler HP; Niklaus G; Loetscher P; Fey MF; Tobler A
Leukemia; 1997 Jan; 11(1):54-63. PubMed ID: 9001419
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor-alpha-induced proliferation requires synthesis of granulocyte-macrophage colony-stimulating factor.
Quentmeier H; Dirks WG; Fleckenstein D; Zaborski M; Drexler HG
Exp Hematol; 2000 Sep; 28(9):1008-15. PubMed ID: 11008013
[TBL] [Abstract][Full Text] [Related]
36. Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1.
Okuda K; Matulonis U; Salgia R; Kanakura Y; Druker B; Griffin JD
Exp Hematol; 1994 Oct; 22(11):1111-7. PubMed ID: 7925778
[TBL] [Abstract][Full Text] [Related]
37. Effect of interleukin-1 beta converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation.
Estrov Z; Black RA; Sleath PR; Harris D; Van Q; LaPushin R; Estey EH; Talpaz M
Blood; 1995 Dec; 86(12):4594-602. PubMed ID: 8541550
[TBL] [Abstract][Full Text] [Related]
38. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells.
Chakraborty A; White SM; Schaefer TS; Ball ED; Dyer KF; Tweardy DJ
Blood; 1996 Oct; 88(7):2442-9. PubMed ID: 8839834
[TBL] [Abstract][Full Text] [Related]
40. The MEK inhibitor, PD98059, reduces survival but does not block acute myeloid leukemia blast maturation in vitro.
Baines P; Fisher J; Truran L; Davies E; Hallett M; Hoy T; Burnett AK
Eur J Haematol; 2000 Apr; 64(4):211-8. PubMed ID: 10776691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
